Comparing two heart medications during surgery
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two medicines, milrinone and epinephrine, given during heart surgery to see which one better helps the right side of the heart work. It may help patients with weaker right heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You are having heart surgery (not a repeat or re-exploration)
- Your heart's pumping ability (ejection fraction) is above 40%
- Your right heart function is reduced (TAPSE less than 1.7 cm)
- You do not have severe lung problems (pulmonary hypertension) or kidney/liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This trial tests whether giving milrinone through a vein and inhaled during mitral valve surgery helps people with severe pulmonary hypertension. The goal is to improve heart and lung blood-flow stability around the time of surgery.
This Phase 2 trial tests whether inhaled medicines (milrinone and epoprostenol) can make it easier to separate from the heart-lung machine during cardiac surgery. It may help reduce the risk of a difficult transition off the machine for the right patients.
This study compares two types of anaesthesia for people with a weakened heart (ejection fraction between 35-40%) who need planned lower-limb surgery. It looks at how each method affects blood pressure and heart function during and after the procedure.
This trial compares two medications, vasopressin and norepinephrine, to see which one better controls blood pressure in the lungs after surgery to remove blockages from the lung arteries. The goal is to find a treatment that keeps the lung blood pressure stable while minimizing side effects.
This early study looks at how well the heart is pumping in people with cardiogenic shock, using measurements taken during a right-heart catheter (a small pressure-monitoring test). It may help doctors better assess heart function and guide next-step treatments like LVAD, heart transplant, or valve surgery.
Hear when a new Cardiac Anaesthesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.